CCXI logo

ChemoCentryx (CCXI) Free Cash Flow

Annual FCF

-$94.64 M
+$1.91 M+1.98%

December 31, 2021

Summary

Performance

1-Year Change

+1.98%

3-Year Change

-706.75%

5-Year Change

-2377.76%

15-Year Change

-2377.76%

CCXI Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$38.84 M
CCXI annual free cash flow is currently -343.66% below its historical high of $38.84 million

3-Year Low

-$94.64 M
CCXI annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
CCXI previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
CCXI next annual earnings announcement has not yet been scheduled

OtherCCXIcash flowmetrics:

Annual CFO

-$75.62 M
CCXI annual cash flow from operations is -$75.62 million

Annual CFF

$1.08 M
CCXI annual cash flow from financing activities is $1.08 million

Annual CFI

$92.22 M
CCXI annual cash flow from investing activities is $92.22 million

Annual CAPEX

$19.02 M
CCXI annual capital expenditures is $19.02 million

Quarterly FCF

-$26.53 M
-$35.14 M-408.24%

June 30, 2022

Summary

Performance

3-Month Change

-408.24%

1-Year Change

-25.45%

3-Year Change

-76.1%

5-Year Change

-86.53%

CCXI Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$67.01 M
CCXI quarterly free cash flow is currently -139.59% below its historical high of $67.01 million

3-Year Low

-$26.53 M
CCXI quarterly free cash flow is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

OtherCCXIcash flowmetrics:

Quarterly CFO

-$26.13 M
CCXI quarterly cash flow from operations is -$26.13 million

Quarterly CFF

$1.86 M
CCXI quarterly cash flow from financing activities is $1.86 million

Quarterly CFI

$28.08 M
CCXI quarterly cash flow from investing activities is $28.08 million

Quarterly CAPEX

$404.00 K
CCXI quarterly capital expenditures is $404.00 thousand

TTM FCF

-$58.97 M
-$5.38 M-10.04%

June 30, 2022

Summary

Performance

3-Month Change

-10.04%

1-Year Change

+42.33%

3-Year Change

+16.84%

5-Year Change

+16.84%

CCXI TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$75.92 M
CCXI TTM free cash flow is currently -177.67% below its historical high of $75.92 million

3-Year Low

-$94.64 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CCXI previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CCXI next earnings announcement has not yet been scheduled

OtherCCXIcash flowmetrics:

TTM CFO

-$53.50 M
CCXI TTM cash flow from operations is -$53.50 million

TTM CFF

$8.16 M
CCXI TTM cash flow from financing activities is $8.16 million

TTM CFI

$12.53 M
CCXI TTM cash flow from investing activities is $12.53 million

TTM CAPEX

$5.47 M
CCXI TTM capital expenditures is $5.47 million

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$94.64 M
CCXI annual free cash flow is -$94.64 million

Annual CFO

-$75.62 M
CCXI annual cash flow from operations is -$75.62 million

Annual CAPEX

$19.02 M
CCXI annual capital expenditures is $19.02 million

CCXI Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+2.0%-25.4%+42.3%
3 y3 years-706.8%-76.1%+16.8%
5 y5 years-2377.8%-86.5%+16.8%

CCXI Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low-408.2%at low+10.0%+60.5%
5 y5-year+33.5%+2.0%-408.2%+22.3%+10.0%+89.5%
alltimeall time-343.7%+2.0%-139.6%+22.3%-177.7%+89.5%

ChemoCentryx Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2022
-
-$26.53 M(-408.2%)
-$58.97 M(+10.0%)
Mar 2022
-
$8.61 M(-175.6%)
-$53.59 M(-43.4%)
Dec 2021
-$94.64 M(-2.0%)
-$11.38 M(-61.6%)
-$94.64 M(-15.3%)
Sep 2021
-
-$29.67 M(+40.3%)
-$111.76 M(+9.3%)
Jun 2021
-
-$21.15 M(-34.8%)
-$102.25 M(+1.6%)
Mar 2021
-
-$32.45 M(+13.9%)
-$100.69 M(+4.3%)
Dec 2020
-$96.55 M(+36.2%)
-$28.50 M(+41.3%)
-$96.55 M(+9.0%)
Sep 2020
-
-$20.16 M(+3.0%)
-$88.61 M(+3.7%)
Jun 2020
-
-$19.58 M(-30.8%)
-$85.41 M(+5.6%)
Mar 2020
-
-$28.31 M(+37.7%)
-$80.89 M(+14.1%)
Dec 2019
-$70.91 M(-554.6%)
-$20.55 M(+21.2%)
-$70.91 M(+7.9%)
Sep 2019
-
-$16.96 M(+12.6%)
-$65.75 M(-1.1%)
Jun 2019
-
-$15.06 M(-17.8%)
-$66.46 M(+52.3%)
Mar 2019
-
-$18.33 M(+19.1%)
-$43.65 M(-379.8%)
Dec 2018
$15.60 M(+275.4%)
-$15.39 M(-12.9%)
$15.60 M(-57.2%)
Sep 2018
-
-$17.67 M(-328.2%)
$36.44 M(-11.4%)
Jun 2018
-
$7.75 M(-81.1%)
$41.14 M(+114.6%)
Mar 2018
-
$40.92 M(+651.0%)
$19.17 M(+361.3%)
Dec 2017
$4.16 M(-89.3%)
$5.45 M(-142.0%)
$4.16 M(-140.5%)
Sep 2017
-
-$12.97 M(-8.8%)
-$10.26 M(+93.1%)
Jun 2017
-
-$14.22 M(-154.9%)
-$5.31 M(-107.0%)
Mar 2017
-
$25.90 M(-388.9%)
$75.92 M(+95.5%)
Dec 2016
$38.84 M
-$8.97 M(+11.7%)
$38.84 M(+0.9%)
Sep 2016
-
-$8.03 M(-112.0%)
$38.50 M(+2.0%)
DateAnnualQuarterlyTTM
Jun 2016
-
$67.01 M(-699.5%)
$37.74 M(-192.2%)
Mar 2016
-
-$11.18 M(+20.1%)
-$40.93 M(+3.5%)
Dec 2015
-$39.55 M(+14.1%)
-$9.31 M(+6.0%)
-$39.55 M(-1.9%)
Sep 2015
-
-$8.78 M(-24.7%)
-$40.32 M(+1.9%)
Jun 2015
-
-$11.67 M(+19.2%)
-$39.56 M(+10.0%)
Mar 2015
-
-$9.79 M(-2.9%)
-$35.96 M(+3.7%)
Dec 2014
-$34.67 M(+2.3%)
-$10.08 M(+25.5%)
-$34.67 M(+11.3%)
Sep 2014
-
-$8.03 M(-0.5%)
-$31.15 M(-2.9%)
Jun 2014
-
-$8.07 M(-5.0%)
-$32.07 M(+0.0%)
Mar 2014
-
-$8.49 M(+29.4%)
-$32.06 M(-5.3%)
Dec 2013
-$33.87 M(+3.6%)
-$6.56 M(-26.7%)
-$33.87 M(-7.1%)
Sep 2013
-
-$8.95 M(+11.0%)
-$36.46 M(+1.8%)
Jun 2013
-
-$8.06 M(-21.8%)
-$35.80 M(-2.1%)
Mar 2013
-
-$10.30 M(+12.6%)
-$36.58 M(+11.9%)
Dec 2012
-$32.70 M(-1104.9%)
-$9.15 M(+10.4%)
-$32.70 M(+348.9%)
Sep 2012
-
-$8.29 M(-6.2%)
-$7.28 M(-3.6%)
Jun 2012
-
-$8.84 M(+37.6%)
-$7.56 M(+40.2%)
Mar 2012
-
-$6.42 M(-139.5%)
-$5.39 M(-265.6%)
Dec 2011
$3.25 M(-81.3%)
$16.27 M(-290.0%)
$3.25 M(-125.0%)
Sep 2011
-
-$8.56 M(+28.4%)
-$13.01 M(+192.4%)
Jun 2011
-
-$6.67 M(-400.6%)
-$4.45 M(-300.6%)
Mar 2011
-
$2.22 M
$2.22 M
Dec 2010
$17.44 M(-175.2%)
-
-
Dec 2009
-$23.18 M(+0.2%)
-
-
Dec 2008
-$23.15 M
-
-

FAQ

  • What is ChemoCentryx annual free cash flow?
  • What is the all time high annual FCF for ChemoCentryx?
  • What is ChemoCentryx annual FCF year-on-year change?
  • What is ChemoCentryx quarterly free cash flow?
  • What is the all time high quarterly FCF for ChemoCentryx?
  • What is ChemoCentryx quarterly FCF year-on-year change?
  • What is ChemoCentryx TTM free cash flow?
  • What is the all time high TTM FCF for ChemoCentryx?
  • What is ChemoCentryx TTM FCF year-on-year change?

What is ChemoCentryx annual free cash flow?

The current annual FCF of CCXI is -$94.64 M

What is the all time high annual FCF for ChemoCentryx?

ChemoCentryx all-time high annual free cash flow is $38.84 M

What is ChemoCentryx annual FCF year-on-year change?

Over the past year, CCXI annual free cash flow has changed by +$1.91 M (+1.98%)

What is ChemoCentryx quarterly free cash flow?

The current quarterly FCF of CCXI is -$26.53 M

What is the all time high quarterly FCF for ChemoCentryx?

ChemoCentryx all-time high quarterly free cash flow is $67.01 M

What is ChemoCentryx quarterly FCF year-on-year change?

Over the past year, CCXI quarterly free cash flow has changed by -$5.38 M (-25.45%)

What is ChemoCentryx TTM free cash flow?

The current TTM FCF of CCXI is -$58.97 M

What is the all time high TTM FCF for ChemoCentryx?

ChemoCentryx all-time high TTM free cash flow is $75.92 M

What is ChemoCentryx TTM FCF year-on-year change?

Over the past year, CCXI TTM free cash flow has changed by +$43.28 M (+42.33%)